ImmunicIMUX
那斯達克 · USD
14.98
+0.27
(+1.84%)
盤中 06/26 02:45 (UTC+8)
06/26 02:45 (UTC+8)
ImmunicIMUX
14.98
+0.27
(+1.84%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 33,235 | 23,327 | 25,993 | 27,083 | 26,825 | 25,631 | 25,726 | 22,814 | 23,881 | 23,381 |
研發費用 | 25,626 | 19,069 | 20,012 | 21,369 | 21,533 | 21,617 | 21,370 | 18,323 | 18,736 | 19,284 |
推銷及管理費用 | 7,609 | 4,258 | 5,981 | 5,714 | 5,292 | 4,014 | 4,356 | 4,491 | 5,145 | 4,097 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -33,235 | -23,327 | -25,993 | -27,083 | -26,825 | -25,631 | -25,726 | -22,814 | -23,881 | -23,381 |
其他收入及費用 | 647 | 4,027 | 414 | 263 | 1,352 | 456 | 1,358 | 1,434 | -5,703 | 1,809 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -32,588 | -19,300 | -25,579 | -26,820 | -25,473 | -25,175 | -24,368 | -21,380 | -29,584 | -21,572 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -32,588 | -19,300 | -25,579 | -26,820 | -25,473 | -25,175 | -24,368 | -21,380 | -29,584 | -21,572 |
基本每股稅後盈餘(元) | -0.11 | -0.04 | -0.13 | -0.20 | -0.25 | -0.25 | -0.24 | -0.21 | -0.30 | - |
稀釋每股稅後盈餘(元) | -0.11 | -0.07 | -0.10 | -0.20 | -0.25 | -0.25 | -0.24 | -0.21 | -0.30 | -0.48 |
基本平均股數(千股) | 301363.00 | 195336.00 | 193897.00 | 132175.00 | 101344.00 | 100856.00 | 101272.00 | 101272.00 | 97299.00 | - |
稀釋平均股數(千股) | 301363.00 | 195336.00 | 193897.00 | 132175.00 | 101344.00 | 100856.00 | 101272.00 | 101272.00 | 97299.00 | - |
還原基本每股稅後盈餘(元) | -1.08 | -0.40 | -1.30 | -2.00 | -2.51 | -2.50 | -2.40 | -2.10 | -3.00 | - |
還原稀釋每股稅後盈餘(元) | -1.08 | -0.70 | -1.00 | -1.99 | -2.51 | -2.50 | -2.40 | -2.10 | -3.00 | -4.80 |
還原基本平均股數(千股) | 30,136 | 19,533 | 19,389 | 13,217 | 10,134 | 10,085 | 10,127 | 10,127 | 9,729 | - |
還原稀釋平均股數(千股) | 30,136 | 19,533 | 19,389 | 13,217 | 10,134 | 10,085 | 10,127 | 10,127 | 9,729 | - |
EBITDA(千元) | -32,555 | -19,258 | -25,539 | -26,777 | -25,430 | -25,140 | -24,326 | -21,349 | -29,558 | -21,549 |